Article info
Clinical and epidemiological research
Extended report
Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry
- Correspondence to Professor J E Gottenberg, Service de Rhumatologie, Hôpitaux Universitaires de Strasbourg, 1 Avenue Molière, 67000 Strasbourg, France; jacques-eric.gottenberg{at}chru-strasbourg.fr
Citation
Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry
Publication history
- Accepted February 25, 2012
- First published May 21, 2012.
Online issue publication
May 12, 2021
Article Versions
- Previous version (12 May 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions